Immune Thrombocytopenia - 36 Studies Found Completed : Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia : Immune Thrombocytopenia : 2017-04-13 : Drug: Rituximab (Mabthera ®) Belimumab (Benlysta ®) Rituximab (Mabthera ®): 1g IV at W0 a Completed : Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001) : Immune Thrombocytopenia Purpura : 2013-10-11 : Drug: MK-8723 MK-8723 administ Terminated : A Study to Investigate the Efficacy and Safety of S-888711 Tablets Administered to Adult Subjects With Immune Thrombocytopenia (ITP) : Immune Thrombocytopenia (ITP) : 2010-01-20 : Drug: placebo to S-888711 Tabl Completed : Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia : Primary Immune Thrombocytopenia : 2012-11-12 Completed : Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP) : Immune Thrombocytopenia (ITP) : 2016-08-11 : Drug: Romiplostim Other Name: AMG531
